704 related articles for article (PubMed ID: 29162051)
1. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry.
Balla MM; Vemuganti GK; Kannabiran C; Honavar SG; Murthy R
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1506-14. PubMed ID: 19029022
[TBL] [Abstract][Full Text] [Related]
3. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
[TBL] [Abstract][Full Text] [Related]
4. A short-term chick embryo
Nair RM; Revu NVL; Gali S; Kallamadi PR; Prabhu V; Manukonda R; Nemani H; Kaliki S; Vemuganti GK
Indian J Ophthalmol; 2022 May; 70(5):1703-1711. PubMed ID: 35502056
[TBL] [Abstract][Full Text] [Related]
5. Human embryonic and neuronal stem cell markers in retinoblastoma.
Seigel GM; Hackam AS; Ganguly A; Mandell LM; Gonzalez-Fernandez F
Mol Vis; 2007 Jun; 13():823-32. PubMed ID: 17615543
[TBL] [Abstract][Full Text] [Related]
6. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
7. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
8. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
[TBL] [Abstract][Full Text] [Related]
10. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
11. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
13. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
Kanwal R; Shukla S; Walker E; Gupta S
Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Narayana RVL; Jana P; Tomar N; Prabhu V; Nair RM; Manukonda R; Kaliki S; Coupland SE; Alexander J; Kalirai H; Kondapi AK; Vemuganti GK
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):13. PubMed ID: 34784412
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma.
Ma B; Lei X; Guan Y; Mou LS; Yuan YF; Yue H; Lu Y; Xu GT; Qian J
Oncol Rep; 2011 Jul; 26(1):135-43. PubMed ID: 21573498
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bmi-1-mediated NF-κB signaling pathway on the stem-like properties of CD133+ human liver cancer cells.
Ma DQ; Zhang YH; Ding DP; Li J; Chen LL; Tian YY; Ao KJ
Cancer Biomark; 2018; 22(3):575-585. PubMed ID: 29843222
[TBL] [Abstract][Full Text] [Related]
20. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.
Puglisi MA; Barba M; Corbi M; Errico MF; Giorda E; Saulnier N; Boninsegna A; Piscaglia AC; Carsetti R; Cittadini A; Gasbarrini A; Sgambato A
J Pathol; 2011 Oct; 225(2):305-14. PubMed ID: 21826669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
